Atreca's Unattributed - IV Round

Atreca raised a round of funding on June 28, 2012.

Atreca is a privately held biotechnology company developing novel therapeutics drawn from human immune responses, including effective anti-cancer immune responses. The company is able to measure and a…

Articles about Atreca's Unattributed - IV Round: